Browsing by Author "Cakmak, E."
Now showing items 1-4 of 4
-
Effect of Vitamin D Treatment on Serum Sclerostin Level
Acibucu, F.; Dokmetas, H. S.; Acibucu, D. O.; Kilicli, F.; Aydemir, M.; Cakmak, E. (JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH, 2017)Objective Sclerostin is an osteocyte-secreted endogenous inhibitor of Wnt signaling. Several systemic and local factors have been suggested as possible regulators of sclerostin expression by osteocytes. In this study, we ... -
INCREASED FREQUENCY OF MEFV GENES IN PATIENTS WITH EPIGASTRIC PAIN SYNDROME
Coskun, B. D.; Kiraz, A.; Sevinc, E.; Baspinar, O.; Cakmak, E. (MACEDONIAN ACAD SCIENCES ARTS, 2017)Atypical clinical forms of familial Mediterranean fever (FMF) can be misdiagnosed as therapy-resistant epigastric pain syndrome (EPS) for they share many of the same clinical features, such as abdominal pain. Thus, we aimed ... -
Steatohepatitis and liver cirrhosis in Chanarin-Dorfman syndrome with a new ABDH5 mutation
Cakmak, E.; Alagozlu, H.; Yonem, O.; Ataseven, H.; Citli, S.; Ozer, H. (ELSEVIER MASSON, 2012)Chanarin-Dorfman syndrome (CDS) is an autosomal recessive neutral lipid storage disease. It is very rare and characterized by ichtiosis, intracellular fat droplets in leucocytes (Jordan anomaly) and involvement of multiple ... -
The view of patients with asthma or chronic obstructive pulmonary disease (COPD) on complementary and alternative medicine
Abadoglu, O.; Cakmak, E.; Demir, S. Kuzucu (ELSEVIER DOYMA SL, 2008)Background: The popularity of complementary and alternative medicine (CAM), particularly for chronic diseases such as asthma, is growing rapidly, but little is known about the characteristics of CAM use by patients with ...